Skip to main content

Table 1 Compilation of studies using lung tissue biomarkers with clinical endpoints

From: Tissue is an issue in the search for biomarkers in idiopathic pulmonary fibrosis

Study

Patients/sample type

Biomarker/method

Clinical endpoint

Main results

[13]

33 IPF

PAR-2

Honeycombing in chest CT

Honeycombing, blood neutrophils, and lymphocytes increased in PAR-2-positive cases

Inflammatory cells in blood and BAL

All fatal cases were PAR-2-positive

SLB

IHC

All-cause mortality

 

[14]

20 IPF

EGFR

Lung function

EGFR mRNA negatively correlated with FVC and DLCO

15 COP

I collagen

15 NSIP

 

10 controls

 
 

IHC

SLB

qRT-PCR

[15]

16 IPF

Inflammatory cells

Lung transplantation

Lymphocytes in lung tissue increased during progression

SLB

 

Lung transplant

HC

[16]

34 IPF

α-SMA

Survival

α-SMA and IL-4 associated with survival

Telomerase

IL-4

TGF-β

β-FGF

SLB

IHC

[17]

48 IPF

Serpin B3/B4

Cancer, dysplasia

High serpin B3/B4 associated with older age and impaired DLCO

Ki-67

Age

TGF-β

Lung function

Lung transplant

IHC

 

RT-PCR

[18]

29 IPF

Chymase

Change in FVC over 6-month period

Mast cell number associated slower rate decline in FVC in IPF

16 HP

CAE

9 SSc-ILD

Eosinophil peroxidase

10 controls

 

SLB

 

Lung transplant

IHC

[19]

19 UIP

SP-A

Prognosis

SP-A+ ratio lower in UIP cases who died

17 NSIP

KL-6

1 COP

 

1 RB-ILD

 

4 IP

 

SLB

IHC

[20]

24 UIP

Gremlin

Lung function

Gremlin mRNA correlates negatively with DLCO/VA and BMP-4 mRNA positively with FVC and DLCO

12 NSIP

BMP-4

Differential diagnostics

SLB

IHC

Gremlin + area in IHC correlated negatively with FVC

Lung transplant

RT-PCR

[21]

20 IPF-UIP

CD68, anti-elastase, CD3, CD4, CD8

Lung function

FEV1 and survival correlated with CD3+ TLs, and CD68+ cells correlated with FEV1 in IPF

20 AIP-DAD

 

Differential diagnostics Survival

20 NSIP

 

SLB

IHC

[22]

12 IPF

CD68, anti-elastase, CD3, CD4, CD8

Lung function

CD8+ TLs correlated inversely with FVC% pred, TLC% pred, DLCO% pred, and PaO2

SLB

IHC

PaO2

Dyspnea score

[23]

IPF 29

LMP-1

Survival

LMP-1+ associated with death due to respiratory failure and use of systemic steroid

SSc-ILD 5

 

Differential diagnostics

SLB

IHC

Systemic steroid treatment

PCR

[24]

28 UIP

Tenascin-C

Survival

High tenascin-C expression correlated with shortened survival in UIP patients

1 NSIP

 

6 DIP

6 sarcoidosis

6 BOOP

6 AA

 

IHC

IEM

SLB

Western blotting

  1. IPF idiopathic pulmonary fibrosis, SLB surgical lung biopsy, IHC immunohistochemistry, CT computed tomography, PAR-2 protease-activated receptor 2, BAL broncho-alveolar lavage, HC histochemistry, α-SMA alpha smooth muscle actin, IL-4 interleukin 4, TGF-β transforming growth factor-beta, FGF fibroblast growth factor, qRT-PCR quantitative reverse transcriptase polymerase chain reaction, DLCO diffusion capacity, HP hypersensitivity pneumonitis, SSc-ILD systemic sclerosis associated interstitial lung disease, CAE chloroacetate esterase, UIP usual interstitial pneumonia, FVC forced vital capacity, NSIP nonspecific interstitial pneumonia, COP cryptogenic organizing pneumonia, BOOP bronchiolitis obliterans organizing pneumonia, RB-ILD respiratory bronchiolitis interstitial lung disease, SP-A surfactant protein A, KL-6 Krebs van den Lungen-6 antigen, BMP-4 bone morphogenic protein 4, AIP acute interstitial pneumonia, DAD diffuse alveolar damage, CD cluster of differentiation, FEV1 forced expiratory volume in 1 s, PaO 2 arterial oxygen tension, LMP-1 latent membrane protein 1, DIP desquamative interstitial pneumonia, IEM immunoelectron microscopy, EGFR epidermal growth factor receptor, TLC total lung capacity, TL T lymphocytes, AA allergic alveolitis.